Develops targeted biologic therapies which improve treatment precision and effectiveness for complex diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Sidewinder Therapeutics develops precision biotechnology therapies using engineered antibody-drug conjugates designed to more accurately target and treat cancer. It focuses on creating advanced biologic treatments that improve targeting specificity and effectiveness by leveraging innovative molecular designs. The company aims to expand treatment possibilities by enhancing how therapies interact with complex disease biology.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Investors
Longwood Fund
Novartis
Goldman Sachs & Co
Samsara BioCapital
Alexandria Venture Investments
DCVC
OrbiMed Advisors
Astellas Venture Management
Frazier Life Sciences Management
Sidewinder Therapeutics Valuations & Financials
View real-time NPM data on Sidewinder Therapeutics stock including daily Sidewinder Therapeutics stock price estimates, valuation history, and historical share price information. Access Sidewinder Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Sidewinder Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Sidewinder Therapeutics? Get in touch to learn more.
Similar Companies
like Sidewinder Therapeutics
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Resilience
Healthcare & Life Sciences
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Benchling
Healthcare & Life Sciences
Cloud based platform for research and development in biotechnology.
Color
Healthcare & Life Sciences
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
Cedar
Healthcare & Life Sciences
The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.
Virta Health
Healthcare & Life Sciences
Online specialty medical clinic focused on reversing type 2 diabetes.
Somatus
Healthcare & Life Sciences
Integrated care for patients with or at risk of developing kidney disease.
FAQ
We have answers
Sidewinder Therapeutics stock does not trade on public stock exchanges. Sidewinder Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Sidewinder Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sidewinder Therapeutics Stock does not trade on public stock exchanges. In order to sell Sidewinder Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Sidewinder Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Sidewinder Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Sidewinder Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Sidewinder Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Sidewinder Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Sidewinder Therapeutics is a private company and has not had an IPO. There is currently no Sidewinder Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Sidewinder Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
